Ankylosing Spondylitis Research Today is a free monthly online journal that collates and summarizes the latest research about Ankylosing Spondylitis, including details on diagnosis, treatment, symptoms, causes.

Volume 2 (2005), Issue 7 (July)

1. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
   Arthritis Rheum, 52(7): 2103-8. [Abstract] [Full-text]
2. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
   Arthritis Rheum, 52(7): 2192-201. [Abstract] [Full-text]
3. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences.
   Ann Rheum Dis, 64(8): 1141-4. [Abstract] [Full-text]
4. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
   Clin Sci (Lond), 109(2): 171-6. [Abstract] [Full-text]
5. Improvement of the clinical outcome in Ankylosing spondylitis by balneotherapy.
   Joint Bone Spine, 72(4): 303-8. [Abstract] [Full-text]
6. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis.
   Arthritis Rheum, 53(3): 445-51. [Abstract] [Full-text]
7. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.
   Arthritis Rheum, 52(6): 1756-65. [Abstract] [Full-text]

© 2004-2008 Ankylosing Spondylitis Research Today. All Rights Reserved.